Skip to content

Based on the thinking of folk traditional Chinese medicine to construct the clinical research scheme of Sequential three debates diagnosis and treatment (''Xu-Guan-Shan-Bian'' system)

Based on the thinking of folk traditional Chinese medicine to construct the clinical research scheme of ''Xu-Guan-Shan-Bian'' system

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003051
Enrollment
Unknown
Registered
2020-02-25
Start date
2020-03-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

Sponsors

The Teaching Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with perennial allergic rhinitis and seasonal allergic rhinitis who meet the diagnostic criteria of allergic rhinitis (allergen skin prick test and serum specific IgE test); 2. The syndrome differentiation of traditional Chinese medicine accords with one of the four types: deficiency of lung qi and cold, weakness of temper, deficiency of kidney yang and stagnation of lung meridian; 3. Aged 18 to 70 years old; 4. Patients who signed informed consent and voluntarily participated in the study process and met the requirements of GCP.

Exclusion criteria

Exclusion criteria: 1. Patients undergoing immunotherapy; 2. Patients with asthma, Henoch Schonlein purpura and other allergic diseases; patients with nasal polyps; 3. Patients with various infectious diseases; 4. Patients suffering from diseases that are easy to be confused and affect the effect (such as those with common cold and upper respiratory tract infection at the same time); 5. Patients with diseases that are easy to cause potential safety hazards (such as patients with serious cardiovascular and cerebrovascular diseases, liver, kidney, blood system diseases or malignant tumors, psychosis, diabetes, and patients with bleeding tendency); 6. Pregnant, lactating and menstrual women; women who plan to be pregnant within half a year; 7 patients who failed to sign the informed consent for the trial or participated in other clinical trials.

Design outcomes

Primary

MeasureTime frame
visual analogue scale;Rhinocoujunctivitis Quality of Life Questionaire;

Countries

China

Contacts

Public ContactLi Xinrong

Chengdu University of Traditional Chinese Medicine

amz.3@163.com+86 13981767185

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026